In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

The 1) Market is expected to reach a substantial USD 34.83 billion by 2033, according to a new report. This reflects a ...

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the discovery of the first monogenic form, ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

The global poultry diagnostics market is on the verge of remarkable expansion, with analysts forecasting a robust Compound Annual Growth Rate (CAGR) of 10.5% over the next decade. Valued at USD 590 ...

Roivant's high valuation is justified, with a strong cash position, promising drug pipeline, and strategic partnerships ...

The global Cattle & Porcine/Swine Reproductive Diseases market is expected to grow to USD 975.8 Million by 2029, up from USD ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...